Arendt, M, Rosenberg, R, Fjordback, L, Brandholdt, J, Foldager, L, Sher, L, Munk-Jørgensen, P (2007). Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychological Medicine 37, 935–945.
Arseneault, L, Cannon, M, Poulton, R, Murray, R, Caspi, A, Moffitt, T (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 325, 1212–1213.
Degenhardt, L, Tennant, C, Gilmour, S, Schofield, D, Nash, L, Hall, W, McKay, D (2007). The temporal dynamics of relationships between cannabis psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychological Medicine 37, 927–934.
Ferdinand, F, van der Ende, J, Bongers, I, Selten, J-P, Huizink, A, Verhulst, FC (2005). A cannabis psychosis pathway independent of other types of psychopathology. Schizophrenia Research 292, 289–295.
Fergusson, DM, Horwood, LJ, Ridder, EM (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354–366.
Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, van Os, J (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11–14.
Kapur, S, Mizrahia, R, Lia, M (2005). From dopamine to salience to psychosis: linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research 79, 59–68.
Macleod, J (2007). Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al. Psychological Medicine 37, 913–916.